BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,501,922 | +56.5% | 284,487 | +2.1% | 0.02% | +57.1% |
| Q2 2023 | $4,792,849 | -22.4% | 278,654 | -25.2% | 0.01% | -30.0% |
| Q1 2023 | $6,177,509 | +120.4% | 372,588 | +1.3% | 0.02% | +122.2% |
| Q4 2022 | $2,802,567 | -26.2% | 367,791 | -1.2% | 0.01% | -35.7% |
| Q3 2022 | $3,799,000 | +25.3% | 372,432 | +8.6% | 0.01% | +27.3% |
| Q2 2022 | $3,033,000 | -12.8% | 343,069 | +0.1% | 0.01% | +10.0% |
| Q1 2022 | $3,480,000 | +65.2% | 342,857 | +171.5% | 0.01% | +100.0% |
| Q4 2021 | $2,106,000 | -31.4% | 126,270 | +92.8% | 0.01% | -28.6% |
| Q3 2021 | $3,070,000 | -22.6% | 65,504 | +0.7% | 0.01% | -30.0% |
| Q2 2021 | $3,964,000 | -39.0% | 65,022 | -38.3% | 0.01% | -44.4% |
| Q1 2021 | $6,494,000 | -35.6% | 105,428 | -25.7% | 0.02% | -33.3% |
| Q4 2020 | $10,087,000 | +154.1% | 141,849 | +34.1% | 0.03% | +92.9% |
| Q3 2020 | $3,969,000 | +22.6% | 105,796 | +6.6% | 0.01% | +16.7% |
| Q2 2020 | $3,237,000 | +68.6% | 99,273 | +49.9% | 0.01% | +9.1% |
| Q1 2020 | $1,920,000 | – | 66,223 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |